Items tagged with Scientific research
International Journal of Mycobacteriology, December 2016 issue (post)
The International Journal of Mycobacteriology is the journal of the Asian-African Society for Mycobacteriology. It is an open access journal and publishes the most current research related to basic, clinical and epidemiological studies of Mycobacterial infection.
How our immune system targets TB (post)
Every 18 seconds someone dies from tuberculosis (TB). It is the world's most deadly infectious disease.
Janssen wins prestigious International Prix Galien award for MDR-TB treatment (post)
PARIS, France, Dec. 8 2016, Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), is proud to accept the prestigious International Prix Galien, recognizing excellence in scientific innovation to improve human health.
Tuberculosis virulence factor identified, may be target for new drug (post)
Scientists have discovered the mechanism that hijacks the immune system's response to tuberculosis, revealing an important new drug target for the disease that kills more than 1 million people each year.
Ancient Chinese malaria remedy fights TB (post)
A centuries-old herbal medicine, discovered by Chinese scientists and used to effectively treat malaria, has been found to potentially aid in the treatment of tuberculosis and may slow the evolution of drug resistance.
Scientists accelerate immune response to TB in mice (post)
New research findings provide insight into the immune system pathways that may be key to developing an effective tuberculosis (TB) vaccine. The study, published in the journal Nature Communications, was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Scientists identify protein central to immune response against tuberculosis bacteria (post)
DALLAS, Jan. 11, 2017 – UT Southwestern Medical Center researchers have identified a protein that is central to the immune system’s ability to recognize and destroy the bacterium responsible for the global tuberculosis (TB) epidemic.
Time to put TB on a diet (post)
TB kills over 1.5 million people a year. Although the mortality rate has dropped by 47% since 1990 due to advances in preventive and treatment options, the tuberculosis bacillus is growing increasingly resistant to antibiotics. For this reason, biochemists at the University of Geneva (UNIGE), Switzerland, are attempting to identify the mechanisms that enable the bacterium to reproduce, spread and survive in latent form in our macrophages. The scientists have discovered that the bacterium has the ability to "reprogramm" the cell it infects so that it can feed on its lipids. The UNIGE research results, which will be published in the PLOS Pathogens journal, will pave the way for new treatment opportunities based on starving and weakening the bacterium.
Plant-based ingredient could lead to improved TB vaccine (post)
The tuberculosis (TB) vaccine hasn’t changed much since it was first used on humans almost a century ago, yet the disease is still prevalent in Canada’s aboriginal communities and in developing countries.
Detecting warning signs of antibiotic resistance in TB (post)
A genomic analysis of more than 5,000 clinical Mycobacterium tuberculosis strains from around the world sheds light on early signs of antibiotic resistance and suggests potential strategies to slow its progression.
Page 21 of 74 · Total posts: 0
←First 20 21 22 Last→